Deferrioxamine B hydrochloride;Desferrioxamine B Hydrochloride;deferoxamine hydrochloride;N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide;hydron;chloride
Multistage process for the preparation of highly pure deferoxamine mesylate salt
申请人:——
公开号:US20030059905A1
公开(公告)日:2003-03-27
The present invention provides a purification process whereby deferoxamine B produced by a microorganism and in mixture with other polyhydroxamates produced by the microorganism may be converted into its mesylate salt substantially free of the other polyhydroxamates and substantially free of chloride ion. The process includes adsorption and desorption of the deferoxamine B on an adsorption resin, direct precipitation of the deferoxamine free base out of the eluent from the adsorption resin, contacting of the deferoxamine B free base with methanesulfonic acid and isolation of the deferoxamine B mesylate salt by precipitation. This process minimizes decomposition of deferoxamine B.
CHELATED IRON-CONTAINING CULTURE MEDIUM FOR NEURAL STEM CELLS
申请人:Ajinomoto Co., Inc.
公开号:EP3279317A1
公开(公告)日:2018-02-07
The present invention provides a medium for neural stem cells and/or neural progenitor cells, which contains chelated iron, and promotes cell proliferation of neural stem cells and/or neural progenitor cells while maintaining undifferentiated state and multipotency, a method of culturing neural stem cells and/or neural progenitor cells by using the medium, and the like.
Chelated iron-containing culture medium for neural stem cells
申请人:AJINOMOTO CO., INC.
公开号:US10968429B2
公开(公告)日:2021-04-06
Culture media, which contain chelated iron, promote cell proliferation of neural stem cells and/or neural progenitor cells while maintaining undifferentiated state and multipotency.
作者:Raymond J. Bergeron、James S. McManis、Otto IV Phanstiel、J. R. Timothy Vinson
DOI:10.1021/jo00106a022
日期:1995.1
A new and versatile route to N'-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]-hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxybutanediamide, deferrioxamine B (DFO), is described. The key improvement over the two prior routes was replacement of the nitrile in 2 with a tert-butoxycarbonyl-protected amino terminus. Elimination of the nitrile improved the kinetics of hydrogenation in that the benzyl groups of 12 were cleaved more rapidly than saturation of the cyano group of 2, and a potential overreduction byproduct (4) was thus avoided. N-(Benzyloxy)-1,5-diaminopentane (6) was selectively protected at the primary amino site with a tert-butoxycarbonyl (BOG) group, providing 7. This was reacted at the (benzyloxy)amine with succinic anhydride to produce carboxylic acid 8, which was in turn acylated regiospecifically with diamine 6 at the primary amine to give (benzyloxy)amine 9. The previous two steps were reiterated to afford DFO reagent 11. This synthon allows for modification of DFO at either end of the molecule, thus providing more flexibility in accessing DFO analogues than any prior route. Acetylation of TI, followed by hydrogenolysis and tert-butoxycarbonyl group removal, furnished DFO.